Michael Davies

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Replacement Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Krista Kinneer, Philipp Wortmann, Zachary A Cooper, Niall J Dickinson, Luke A Masterson, Thais Cailleau, Ian Hutchinson, Balakumar Vijayakrishnan, Mary McFarlane, Kathryn Ball, Michael Davies, Arthur Lewis, Yue Huang, Anton I Rosenbaum, Jiaqi Yuan, Jon Chesebrough, Judith Anderton, Noel Monks, Steven J Novick, Jixin Wang, Nazzareno Dimasi, R James Christie, Darrin Sabol, Frances Anne Tosto, Yann Wallez, Elisabetta Leo, Mark R Albertella, Anna D Staniszewska, David A Tice, Philip W Howard, Nadia Luheshi, Puja Sapra
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Atanu Chakraborty, Lyndsey Hanson, David Robinson, Hilary J Lewis, Sue Bickerton, Michael Davies, Radoslaw Polanski, Rebecca Whiteley, Alex Koers, James Atkinson, Tamara Baker, Ivan Del Barco Barrantes, Giovanni Ciotta, Jason G Kettle, Lukasz Magiera, Carla P Martins, Alison Peter, Eleanor M Wigmore, Zoe E Underwood, Sabina Cosulich, Michael Niedbala, Sarah J Ross
AZD4625 is a Potent and Selective Inhibitor of KRASG12C. Molecular cancer therapeutics 21 (10) (2022)